A retrospective observational study on biological drug treatment in a daily practice serving patients with psoriasis in Japan

Background: In Japan, more than five years have passed since emergence of the first three biologics, infliximab, adalimumab, and ustekinumab, became available in daily practice; however, no data for drug survival was reported from Japan. Objective: To study the long-term drug survival of infliximab,...

Full description

Bibliographic Details
Main Authors: Chika Ohata, Bungo Ohyama, Aya Nanri, Takako Shintani, Takekuni Nakama
Format: Article
Language:English
Published: Taylor & Francis Group 2019-01-01
Series:Journal of Dermatological Treatment
Subjects:
Online Access:http://dx.doi.org/10.1080/09546634.2018.1468064